Browse

You are looking at 351 - 400 of 1,337 items for :

  • Clinical Resources x
  • Refine by Access: All content x
Clear All
Restricted access

Eslicarbazepine Acetate Suspension 40 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

CH 1.3 Estimating Kidney Function

John E. Murphy

Restricted access

CH 2.3 Estimating Kidney Function

John E. Murphy

Restricted access

Ethacrynic Acid Solution 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

14 ETHOSUXIMIDE

Jacquelyn L. Bainbridge, Pei Shieen Wong, Sarah N. Rajkovic, and Grace S. Chin

Restricted access

Etoposide Solution 10 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access
Cover Extemporaneous Formulations

Extemporaneous Formulations

for Pediatric, Geriatric, and Special Needs Patients

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Famotidine Suspension 8 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Famotidine Syrup 8 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Flecainide Acetate Suspension 20 mg/mL—Formulation 1*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Flecainide Acetate Suspension 20 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Fluconazole Solution 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Flucytosine Suspension 10 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Flucytosine Suspension 50 mg/mL*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Fluoxetine Hydrochloride Syrup 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Fluoxetine Hydrochloride Syrup 2 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Furosemide Suspension 2 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Furosemide Suspension 9.6 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Gabapentin Suspension 100 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Gabapentin Suspension 100 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Gabapentin Suspension 50 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Ganciclovir Intravitreous Solution 20 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Free access

CH 1.1 General Pharma­cokinetic Applications

John E. Murphy

Restricted access

CH 2.1 General Pharmacokinetic Applications

John E. Murphy

Restricted access

Gentamicin Sulfate Ophthalmic Solution 13.6 mg/mL (Fortified)

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Glutamine Suspension 250 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Glycopyrrolate Suspension 0.2 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Glycopyrrolate Suspension 0.5 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Glycopyrrolate Suspension 0.5 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Granisetron Hydrochloride Suspension 0.05 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Granisetron Hydrochloride Syrup 0.2 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Haloperidol Suspension 0.5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

17 Hematology: Blood Coagulation Tests

Lea E. Dela Peña

Restricted access

16 Hematology: Red and White Blood Cell Tests

Michael D. Katz and Timothy C. Jacisin

Restricted access

Hydralazine Hydrochloride Suspension 4 mg/mL*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Hydrochlorothiazide Suspension 2 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Hydrocortisone Hemisuccinate Suspension 2 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Hydrocortisone Sodium Phosphate Suspension 2 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Hydrocortisone Suspension 1 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Hydrocortisone Suspension 1 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Hydrocortisone Suspension 2 mg/mL*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Hydroxychloroquine Sulfate Suspension 25 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Hydroxyurea Syrup 100 mg/mL*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Hypromellose Suspension 10 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Imatinib Syrup 40 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Imipramine Hydrochloride Suspension 5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Indinavir Liquid 10 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Indomethacin Syrup 2 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

18 Infectious Diseases: Bacteria

Sharon M. Erdman, Rodrigo M. Burgos, and Keith A. Rodvold

Restricted access

19 Infectious Diseases: Fungi, Viruses, and Mycobacteria

Rodrigo M. Burgos, Sharon M. Erdman, and Keith A. Rodvold